DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

OXIGENE, INC. (NASDAQ: OXGN)



company name or ticker

Stocks Hitting 52-Week Lows

OXiGENE Reports Publication of Final FACT Study Data in Journal Thyroid, Study Suggests Survival Ben

OXiGENE Reports Publication of Final FACT Study Data in Journal Thyroid, Study Suggests Survival Benefit of ZYBRESTAT

OXiGENE Management Discusses Q1 2013 Results - Earnings Call Transcript

OXiGENE's Oncology Drugs Have Run Their Course

OXiGENE Closes Enrollment of ZYBRESTAT Phase 2 Ovarian Cancer Trial

OXiGENE Announces $5M Private Placement

Morning Market Movers

Stocks Hitting 52-Week Lows

Solving The R&D Investment Dilemma With Project Funding: Mark Kessel

OXiGENE Announces Patent for Benzosuberenes